Company to Host Conference Call on
Wednesday, November 1, 2023 at
1:30 pm PT / 4:30 pm ET
REDWOOD
CITY, Calif., Oct. 4, 2023
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical
device company that is delivering comprehensive, life-changing
solutions for the treatment of chronic pain, today
announced that the company will report its financial results
for the third quarter ended September 30,
2023 after the market closes on November 1, 2023.
Management will host a conference call on November 1, 2023 to discuss third quarter 2023
financial results. The call will begin at 1:30 pm PT/ 4:30 pm
ET. Investors interested in listening to the call may
do so by dialing (888) 330-2443 in the U.S. or +1 (240) 789-2728
internationally, using Conference ID: 3583097. A live webcast of
this event, as well as an archived recording, will be available in
the Investors section of Nevro's website at www.nevro.com.
Internet Posting of Information
Nevro routinely
posts information that may be important to investors in the
"Investor Relations" section of its website at
www.nevro.com. The company encourages investors and potential
investors to consult the Nevro website regularly for
important information about Nevro.
About Nevro
Headquartered in Redwood City, California, Nevro
is a global medical device company focused on delivering
comprehensive, life-changing solutions that continue to set the
standard for enduring patient outcomes in chronic pain treatment.
The company started with a simple mission to help more patients
suffering from debilitating pain and developed its proprietary 10
kHz Therapy™, an evidence-based, non-pharmacologic innovation that
has impacted the lives of more than 100,000 patients
globally. Nevro's comprehensive HFX™
spinal cord stimulation (SCS) platform includes
a SenzaTM SCS system and support services
for the treatment of chronic pain of the trunk and limb and painful
diabetic neuropathy.
Senza®, Senza II®, Senza Omnia™, and HFX iQ™ are the only SCS
systems that deliver Nevro's proprietary 10 kHz Therapy. Nevro's
unique support services provide every patient with an HFX Coach™
throughout their pain relief journey and every physician with HFX
Cloud™ insights for enhanced patient and practice management.
SENZA, SENZA II, SENZA OMNIA, OMNIA, HF10, the HF10 logo, 10 kHz
Therapy, HFX, the HFX logo, HFX iQ, the HFX iQ logo, HFX Algorithm,
HFX CONNECT, the HFX Connect logo, HFX ACCESS, the HFX Access logo,
HFX COACH, the HFX Coach logo, HFX CLOUD, the HFX Cloud logo,
RELIEF MULTIPLIED, the X logo, NEVRO, and the NEVRO logo are
trademarks or registered trademarks of Nevro Corp. Patents covering
Senza HFX iQ and other Nevro products are listed at
Nevro.com/patents.
To learn more about Nevro, connect with us
on LinkedIn, Twitter, Facebook, and Instagram.
Investors and Media:
Nevro
Corp.
ir@nevro.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/nevro-to-report-third-quarter-2023-financial-results-301946567.html
SOURCE Nevro Corp.